Cambridge University, Department of Surgery, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Cambridge Advanced Imaging Centre, University of Cambridge, Cambridge, UK.
J Tissue Eng Regen Med. 2020 Oct;14(10):1502-1512. doi: 10.1002/term.3117. Epub 2020 Aug 24.
Liver transplantation is the only life-saving treatment for end-stage liver failure but is limited by the organ shortage and consequences of immunosuppression. Repopulation of decellularised scaffolds with recipient cells provides a theoretical solution, allowing reliable and timely organ sourcing without the need for immunosuppression. Recellularisation of the vasculature of decellularised liver scaffolds was investigated as an essential prerequisite to the survival of other parenchymal components. Liver decellularisation was carried out by portal vein perfusion using a detergent-based solution. Decellularised scaffolds were placed in a sterile perfusion apparatus consisting of a sealed organ chamber, functioning at 37°C in normal atmospheric conditions. The scaffold was perfused via portal vein with culture medium. A total of 10 primary cultured bone marrow stem cells, selected by plastic adherence, were infused into the scaffold, after which repopulated scaffolds were perfused for up to 30 days. The cultured stem cells were assessed for key marker expression using fluorescence-activated cell sorting (FACS), and recellularised scaffolds were analysed by light, electron and immunofluorescence microscopy. Stem cells were engrafted in portal, sinusoidal and hepatic vein compartments, with cell alignment reminiscent of endothelium. Cell surface marker expression altered following engraftment, from haematopoietic to endothelial phenotype, and engrafted cells expressed sinusoidal endothelial endocytic receptors (mannose, Fc and stabilin receptors). These results represent one step towards complete recellularisation of the liver vasculature and progress towards the objective of generating transplantable neo-organs.
肝移植是治疗终末期肝功能衰竭的唯一救命方法,但受到器官短缺和免疫抑制后果的限制。用受体细胞再种植去细胞化支架提供了一种理论上的解决方案,允许可靠和及时地获取器官,而无需免疫抑制。去细胞化肝支架的血管再种植被认为是其他实质成分存活的基本前提。采用基于去污剂的溶液通过门静脉灌注进行肝去细胞化。将去细胞化的支架放置在无菌灌注装置中,该装置由密封的器官室组成,在正常大气条件下于 37°C 下工作。通过门静脉用培养基对支架进行灌注。在将支架灌注长达 30 天之前,将通过塑料粘附选择的总共 10 个原代培养骨髓干细胞注入支架中。用荧光激活细胞分选(FACS)评估培养的干细胞的关键标记物表达,并通过光、电子和免疫荧光显微镜分析再种植的支架。干细胞在门静脉、窦状隙和肝静脉隔室中定植,细胞排列类似于内皮细胞。定植后细胞表面标记物的表达发生变化,从造血细胞表型转变为内皮细胞表型,并且定植的细胞表达了窦状内皮细胞内吞受体(甘露糖、Fc 和稳定素受体)。这些结果是肝血管完全再种植的重要一步,也是实现生成可移植新器官的目标的进展。